Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results

Published: 31 July 2024Medical congresses & eventsFinancial Investment & Stock

Oslo, Norway, 31 July 2024: Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2024 financial results on Wednesday 7 August 2024 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.

The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CEST.

The streaming event is available through

https://channel.royalcast.com/landingpage/hegnarmedia/20240807_1/

For further information, please contact:

Photocure 
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure 
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act

News and events